Gene · 4919
Papers2,258
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,258
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Serum biomarkers in patients with drug-resistant epilepsy: a proteomics-based analysis. | Front Neurol | 2024 | 38585359 | PubTator, text mining | PubMed |
| Characterization and impact of non-canonical WNT signaling on outcomes of urothelial carcinoma. | Cancer Med | 2024 | 38558536 | PubTator, text mining | PubMed |
| A Crosstalk between the Receptor Tyrosine Kinase-Like Orphan Receptors ROR1/2 and S1P Signaling Pathways in Lung Cancer. | Asian Pac J Cancer Prev | 2024 | 38546054 | PubTator, text mining | PubMed |
| Performance of a novel eight-color flow cytometry panel for measurable residual disease assessment of chronic lymphocytic leukemia. | Cytometry B Clin Cytom | 2024 | 38535092 | PubTator, text mining | PubMed |
| Wnt5a/β-catenin-mediated epithelial-mesenchymal transition: a key driver of subretinal fibrosis in neovascular age-related macular degeneration. | J Neuroinflammation | 2024 | 38532410 | PubTator, text mining | PubMed |
| Role of Wnt5b-Ror1 signaling in the proliferation of pancreatic ductal adenocarcinoma cells. | Genes Cells | 2024 | 38531660 | PubTator, text mining | PubMed |
| Using protein geometry to optimize cytotoxicity and the cytokine window of a ROR1 specific T cell engager. | Front Immunol | 2024 | 38455046 | PubTator, text mining | PubMed |
| Quantitative Investigation of Neuroprotective Role of ROR1 in a Cell Culture Model of Alzheimer's Disease. | Methods Mol Biol | 2024 | 38427243 | PubTator, text mining | PubMed |
| A phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic Her2-negative breast cancer. | Breast Cancer Res | 2024 | 38408999 | PubTator, text mining | PubMed |
| Correction: ROR1-targeting switchable CAR-T cells for cancer therapy. | Oncogene | 2024 | 38383728 | PubTator, text mining | PubMed |
| Prognostic Markers in Tyrosine Kinases Specific to Basal-like 2 Subtype of Triple-Negative Breast Cancer. | Int J Mol Sci | 2024 | 38338684 | PubTator, text mining | PubMed |
| Long noncoding RNA DLEU2 and ROR1 pathway induces epithelial-to-mesenchymal transition and cancer stem cells in breast cancer. | Cell Death Discov | 2024 | 38296962 | PubTator, text mining | PubMed |
| The evolving roles of Wnt signaling in stem cell proliferation and differentiation, the development of human diseases, and therapeutic opportunities. | Genes Dis | 2024 | 38292186 | PubTator, text mining | PubMed |
| ROR1 expression in mature B lymphoid neoplasms by flow cytometry. | Cytometry B Clin Cytom | 2024 | 38273649 | PubTator, text mining | PubMed |
| A Comprehensive Review of Immunotherapy Clinical Trials for Metastatic Urothelial Carcinoma: Immune Checkpoint Inhibitors Alone or in Combination, Novel Antibodies, Cellular Therapies, and Vaccines. | Cancers (Basel) | 2024 | 38254823 | PubTator, text mining | PubMed |
| Adipo-oncology: adipocyte-derived factors govern engraftment, survival, and progression of metastatic cancers. | Cell Commun Signal | 2024 | 38238841 | PubTator, text mining | PubMed |
| Bone marrow-derived mesenchymal stromal cells obstruct AML-targeting CD8+ clonal effector and CAR T-cell function while promoting a senescence-associated phenotype. | Cancer Immunol Immunother | 2024 | 38231344 | PubTator, text mining | PubMed |
| Ameliorating impact of coenzyme Q10 on the profile of adipokines, cardiomyopathy, and hematological markers correlated with the glucotoxicity sequelae in diabetic rats. | PLoS One | 2024 | 38227584 | PubTator, text mining | PubMed |
| Chimeric Antigen Receptor T Cell Therapy for Pancreatic Cancer: A Review of Current Evidence. | Cells | 2024 | 38201305 | PubTator, text mining | PubMed |
| Non-coding RNAs as potential therapeutic targets for receptor tyrosine kinase signaling in solid tumors: current status and future directions. | Cancer Cell Int | 2024 | 38200584 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4919/papers?page=10